|Mr. Nasrat Hakim||Chairman, Pres & Chief Exec. Officer||1.02M||N/A||56|
|Mr. Carter J. Ward CPA, CSCP||Chief Financial Officer, Chief Accounting Officer, Treasurer & Sec.||192.82k||N/A||53|
|Mr. Douglas Plassche||Exec. VP of Operations||335.62k||N/A||53|
|Dr. George Kenneth Smith J.D., M.B.A., Ph.D.||VP of Legal||412k||N/A||N/A|
|Ms. Dianne Will||VP of Investor Relations & Corp. Affairs||N/A||N/A||N/A|
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, ANDAs for Generic Products and NDAs for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 15mg, 30mg, and 37.5mg tablets and capsules for the treatment of bariatrics under Adipex-P brand name; Lodrane D immediate release capsules for OTC allergy treatment; Methadone HCl 10mg tablets for pains under the Dolophine brand name; and Hydromorphone HCl 8mg tablets for pains under the Dilaudid brand name. The company also provides Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril name; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia name; Isradipine 2.5mg and 5mg capsules for cardiovascular diseases; Hydroxyzine HCl 10mg, 25mg, and 50mg tablets for antihistamine treatment under Atarax and Vistaril brand names; and Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand name. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company has a sales and distribution licensing agreement with Epic Pharma LLC; manufacturing and license agreement with Epic Pharma LLC; manufacturing and supply agreement with ThePharmaNetwork LLC; marketing and distributing agreement with Precision Dose Inc.; and development agreement with Akorn Pharmaceuticals. Elite Pharmaceuticals, Inc. was founded in 1984 and is headquartered in Northvale, New Jersey.
Elite Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.